No earnings within 2 weeks of this transaction.
| Insider | Sandercock Brett |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Mar 2, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | ResMed Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 3, 2026 |
| Shares Sold | 1,000 |
| Price per Share | $254.30 |
| Total Value | $254,300.00 |
| Shares Owned After | 84,495 |
| Derivative | No |
| Accession Number | 0000943819-26-000013 |
| Document | View SEC Filing |